Citations in PubMed

Primary Citation PubMed: 15177479 Citations in PubMed

PDB ID Mentions in PubMed Central Article count: 2

Citations in PubMed

This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.

PDB ID Mentions in PubMed Central

Data mentions are occurrences of PDB IDs in the full text articles from the PubMedCentral Open Access Subset of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed. Article titles can be filtered by keywords and sorted by year.

  • 3 per page
  • 5 per page
  • 10 per page
  • view all
  • Publication Year
  • Ascending
  • Descending

A comparative reverse docking strategy to identify potential antineoplastic targets of tea functional components and binding mode.

(2011) Int J Mol Sci 12

PubMed: 21954353 | PubMedCentral: PMC3179160 | DOI: 10.3390/ijms12085200

PDB_ID Target Name Predicted by Procedures Implicated by Experiment Energy Score (kcal/mol) Reference or Related Disease 3BCH 67 kD laminin receptor Autodock YES −3.75 [ 2 ] 7HVP HIV protease ... utodock/Tarfisdock YES −5.01/−44.87 [ 18 ] 1GRE glutathione reductase Autodock YES −6.80 [ 19 , 20 ] 1IJH cholesterol oxidase Autodock YES −6.77 [ 21 ] 8CAT catalase Autodock YES −6.23 [ 22 ] 1JNY eEF1-α Autodock YES −5.70 [ 3 ] 1BOO DNA methyltransferase Autodock YES −4.66 [ 23 ] 2OZO ZAP-70 Autodock YES −3.81 [ 24 ] 2DQ7 Fyn kinase Autodock YES −4.91 [ 25 ] 1HS6 Leukotriene A4 Autodock/Tarfisdock NO −5.22/−48.2 Esophagus cancer 1FT2 Farnesyl protein transferase Autodock/Tarfisdock NO −4.1/−44.94 Cancer/Tumour 1UTR Mammalian PCB-binding protein Autodock NO −7.19 Lung Cancer 1JVM Voltage-Gated Potassium Channel Autodock NO −6.58 Cardiomyopathie 1OG5 CYP450 Autodock NO −6.49 Tumour 1VKG Histone deacetylase Autodock NO −5.63 Tumour 1OOQ Dihyrofolate reductase Tarfisdock NO −46.42 Tumour 1IYH Hematopoietic Prostagladin Synthase Tarfisdock NO −44.50 Cancer 1PY5 TGF-beta receptor type I Tarfisdock NO −44.33 Renal carcinoma Table 2.

Publication Year: 2011

Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy.

(2014) Cancers (Basel) 6

PubMed: 24670367 | PubMedCentral: PMC4074797 | DOI: 10.3390/cancers6020663

There are many small molecule receptor kinase inhibitor structures in the PDB (PDB_Codes: 1py5, 1rw8, 1vjy, 2wot, 2wou, 2x7o, 3faa, 3gxl, 3hmm, 3kcf and 3tzm), targeting the protein kinase domain of T... FBR1 as it is involved in its interactions with the downstream proteins.

Publication Year: 2014